Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Conmed (CNMD) Operating Income (2016 - 2025)

Conmed's Operating Income history spans 16 years, with the latest figure at $36.6 million for Q4 2025.

  • For Q4 2025, Operating Income fell 30.24% year-over-year to $36.6 million; the TTM value through Dec 2025 reached $102.6 million, down 48.77%, while the annual FY2025 figure was $102.6 million, 48.77% down from the prior year.
  • Operating Income reached $36.6 million in Q4 2025 per CNMD's latest filing, up from $11.9 million in the prior quarter.
  • In the past five years, Operating Income ranged from a high of $65.7 million in Q3 2024 to a low of -$1.1 million in Q4 2022.
  • Average Operating Income over 5 years is $30.2 million, with a median of $27.1 million recorded in 2021.
  • Peak YoY movement for Operating Income: crashed 102.94% in 2022, then soared 4683.29% in 2023.
  • A 5-year view of Operating Income shows it stood at $37.2 million in 2021, then tumbled by 102.94% to -$1.1 million in 2022, then skyrocketed by 4683.29% to $50.2 million in 2023, then grew by 4.61% to $52.5 million in 2024, then tumbled by 30.24% to $36.6 million in 2025.
  • Per Business Quant, the three most recent readings for CNMD's Operating Income are $36.6 million (Q4 2025), $11.9 million (Q3 2025), and $38.2 million (Q2 2025).